Vaccination of 27- to 45-Year-Olds Against HPV Is Less Cost-Effective

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

TUESDAY, Nov. 26, 2024 -- Vaccination of 27- to 45-year-olds ("mid-adults") against human papillomavirus (HPV) is less cost-effective than vaccination of younger persons (aged 9 to 26 years), according to a study published online Nov. 26 in the Annals of Internal Medicine.

Jean-François Laprise, Ph.D., from the Centre de recherche du CHU de Québec-Université Laval in Québec City, and colleagues examined the incremental cost-effectiveness ratios (ICERs) and number needed to vaccinate (NNV) to prevent one HPV-related cancer case for expanding HPV vaccination to subgroups of mid-adults and those at higher risk.

The researchers found that the projected costs increased by $2,005,000, $763,000, and $1,164,000 per quality-adjusted life-year (QALY) gained for expanding 9-valent HPV vaccination to all mid-adults, those with more lifetime partners, and those who have just separated, respectively. To prevent one additional HPV-related cancer case, the NNVs were 7,670, 3,190, and 5,150, respectively, compared with 223 for vaccination of those aged 9 to 26 years. In the sensitivity analysis, vaccinating infrequently screened mid-adult women who have just separated and have a higher number of lifetime sex partners was the mid-adult strategy with the lowest ICER and NNV (ICER, $86,000 per QALY gained; NNV, 470).

"HPV vaccination of mid-adults remains much less cost-effective and produces much higher NNVs than vaccinating females and males aged 26 years or younger under all scenarios investigated," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords